Clinical trial · Interventional
Effects of Parenteral Nutrition in HSCT
Effects of Parenteral Nutrition in Hematopoietic Stem Cell Transplantation: a Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Nutritional therapy implementation in hematopoietic stem cell transplantation (HSCT) have undergone changes recently due to new conditioning regimen and graft versus disease prophylaxis, novel enteral and parenteral nutrition solutions: the value of enteral nutrition is increasing, the indications for parenteral nutrition are becoming more strict. The study aims to identify the role of parenteral nutrition in the context of rapidly changing supportive care approaches in HSCT
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematologic Malignancy | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Glucose/Amino acids | Drug | — | UNRESOLVED |
| Glucose/Amino acids/Lipids | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Glucose/Amino acids
- description
- Patients who will require nutritional support will receive parenteral nutrition consisting of glucose and amino acids according age and weight
- interventionNames
- Drug: Glucose/Amino acids
- type
- EXPERIMENTAL
- label
- Glucose/Amino acids/Lipids
- description
- Patients who will require nutritional support will receive parenteral nutrition consisting of glucose, amino acids and lipid emulsions according age and weight
- interventionNames
- Drug: Glucose/Amino acids/Lipids
Primary outcomes (1)
- measure
- Number of patients with low tolerability of different parenteral nutrition schemes in HSCT According CTCAE ver. 5.0
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 2 Years
Show eligibility criteria text
Inclusion Criteria: * Autologous HSCT * Allogeneic HSCT * Patients with indications for parenteral nutrition defined as unable to eat more than 50% of oral food intake due to posttransplant complications which leads to malnutrition and malabsorption * Signed informed consent * Age \> 2 years Exclusion Criteria: \- Secondary HSCT
References
Publications (0)
Data not yet available